Studies Related to the Impact of Pharmacists on Mental Health Outcomes

The studies identified below are part of a systematic review that is pending publication. Methods, additional study details, and meta-analysis will be included in that publication. The table below indicates which types of outcomes were collected in each study.

Resource Utilization
Response
Adverse Outcomes
Time-based
Satisfaction/Attitude/Adherence
Retention/Referral
Cost-based
Medication-based
  
  1     1       AbuNaba'a Y, Basheti IA. Assessing the impact of medication management review service for females diagnosed with depression and anxiety: A randomized control trial. J Eval Clin Pract. 2020 Oct;26(5):1478-1489. Epub 2019 Nov 6. PMID: 31692212. DOI: 10.1111/jep.13314..
  1           1 Adler DA, Bungay KM, Wilson IB, Pei Y, Supran S, Peckham E, Cynn DJ, Rogers WH. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry. 2004 May-Jun;26(3):199-209. PMID: 15121348. DOI: 10.1016/j.genhosppsych.2003.08.005..
  1 1           Ahmed S, Tahir R, Akhtar U, Faiz M. Pharmacogenomics Guided Prescription Changes Improved Medication Effectiveness in Patients With Mental Health-Related Disability: A Retrospective Cohort Analyses. Front Genet. 2021 Aug 3;12:644694. eCollection 2021. PMID: 34413872. DOI: 10.3389/fgene.2021.644694..
    1           Ahrens TN, Sramek JJ, Herrera JM, Jewett CM, Alcorn VE. Pharmacy-based screening program for tardive dyskinesia. Drug Intell Clin Pharm. 1988 Mar;22(3):205-8. PMID: 2896586. DOI: 10.1177/106002808802200305..
        1       Aljumah K, Hassali MA. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry. 2015 Sep 16;15:219. PMID: 26376830. DOI: 10.1186/s12888-015-0605-8..
  1             Alkoudsi KT, Basheti IA. Prevalence of anxiety and depression among women with Polycystic Ovary Syndrome living in war versus non-war zone countries: A randomized controlled trial assessing a pharmacist intervention. Res Social Adm Pharm. 2020 May;16(5):689-698. Epub 2019 Aug 9. PMID: 31420190. DOI: 10.1016/j.sapharm.2019.08.027..
        1       Al-Saffar N, Abdulkareem A, Abdulhakeem A, Salah AQ, Heba M. Depressed patients' preferences for education about medications by pharmacists in Kuwait. Patient Educ Couns. 2008 Jul;72(1):94-101. Epub 2008 Mar 11. PMID: 18337052. DOI: 10.1016/j.pec.2008.01.027..
  1             Augustine JM, Taylor AM, Pelger M, Schiefer D, Warholak TL. Smoking quit rates among patients receiving pharmacist-provided pharmacotherapy and telephonic smoking cessation counseling. J Am Pharm Assoc (2003). 2016 Mar-Apr;56(2):129-36. PMID: 27000162. DOI: 10.1016/j.japh.2016.02.001..
  1           1 Badr AF, Kurdi S, Alshehri S, McManus C, Lee J. Pharmacists' interventions to reduce sedative/hypnotic use for insomnia in hospitalized patients. Saudi Pharm J. 2018 Dec;26(8):1204-1207. Epub 2018 Jul 20. PMID: 30510473. DOI: 10.1016/j.jsps.2018.07.010..
  1     1       Baluch WM. Pharmacists' role in a smoking-cessation program at a health maintenance organization. Am J Health Syst Pharm. 1995 Feb 1;52(3):287-93. PMID: 7749956. DOI: 10.1093/ajhp/52.3.287..
1               Bättig VAD, Roll SC, Hahn M. Pharmacogenetic Testing in Depressed Patients and Interdisciplinary Exchange between a Pharmacist and Psychiatrists Results in Reduced Hospitalization Times. Pharmacopsychiatry. 2020 Jul;53(4):185-192. Epub 2020 Feb 11. PMID: 32045941. DOI: 10.1055/a-1096-1171..
                Bauld L, Boyd KA, Briggs AH, Chesterman J, Ferguson J, Judge K, Hiscock R. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine Tob Res. 2011 Feb;13(2):135-45. Epub 2010 Dec 31. PMID: 21196451. DOI: 10.1093/ntr/ntq222..
  1             Beaupre LA, Hammal F, Stiegelmar R, Masson E, Finegan B. A community-based pharmacist-led smoking cessation program, before elective total joint replacement surgery, markedly enhances smoking cessation rates. Tob Induc Dis. 2020 Sep 14;18:78. eCollection 2020. PMID: 33013274. DOI: 10.18332/tid/126405..
1             1 Berchou RC. Effect of a consultant pharmacist on medication use in an institution for the mentally retarded. Am J Hosp Pharm. 1982 Oct;39(10):1671-4. PMID: 6128921FALSE.
  1             Bingham J, Axon DR, Scovis N, Taylor AM. Evaluating the Effectiveness of Clinical Pharmacy Consultations on Nutrition, Physical Activity, and Sleep in Improving Patient-Reported Psychiatric Outcomes for Individuals with Mental Illnesses. Pharmacy (Basel). 2018 Dec 22;7(1):2. PMID: 30583547. DOI: 10.3390/pharmacy7010002..
1   1       1   Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy. Pharmacotherapy. 2006 Oct;26(10):1369-78. PMID: 16999646. DOI: 10.1592/phco.26.10.1369..
1   1         1 Bond CA, Salinger RJ. Fluphenazine outpatient clinics: a pharmacist's role. J Clin Psychiatry. 1979 Dec;40(12):501-3. PMID: 500572FALSE.
  1     1       Bouchet-Benezech B, Champanet B, Rouzaud P. Smoking cessation at the pharmacy: feasibility and benefits based on a French observational study with six-month follow-up. Subst Abuse Rehabil. 2018 Jul 17;9:31-42. eCollection 2018. PMID: 30046265. DOI: 10.2147/SAR.S152186..
  1     1       Boudreau DM, Capoccia KL, Sullivan SD, Blough DK, Ellsworth AJ, Clark DL, Katon WJ, Walker EA, Stevens NG. Collaborative care model to improve outcomes in major depression. Ann Pharmacother. 2002 Apr;36(4):585-91. PMID: 11918503. DOI: 10.1345/aph.1A259..
    1           Bransgrove LL, Kelly MW. Movement disorders in patients treated with long-acting injectable antipsychotic drugs. Am J Hosp Pharm. 1994 Apr 1;51(7):895-9. PMID: 7912473FALSE.
  1           1 Bravo-José P, Sáez-Lleó CI, Peris-Martí JF. Deprescribing antipsychotics in long term care patients with dementia. Farm Hosp. 2019 Jul 1;43(4):140-145. PMID: 31276444. DOI: 10.7399/fh.11217..
  1   1     1 1 Brophy GM, Tesoro EP, Schrote GL, Garnett WR. Pharmacist impact on posttraumatic seizure prophylaxis in patients with head injury. Pharmacotherapy. 2002 Feb;22(2):251-5. PMID: 11837562. DOI: 10.1592/phco.22.3.251.33547..
  1             Bruhn H, Bond CM, Elliott AM, Hannaford PC, Lee AJ, McNamee P, Smith BH, Watson MC, Holland R, Wright D. Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial. BMJ Open. 2013 Apr 5;3(4):e002361. Print 2013. PMID: 23562814. DOI: 10.1136/bmjopen-2012-002361..
  1     1       Buist E, McLelland R, Rushworth GF, Stewart D, Gibson-Smith K, MacLure A, Cunningham S, MacLure K. An evaluation of mental health clinical pharmacist independent prescribers within general practice in remote and rural Scotland. Int J Clin Pharm. 2019 Oct;41(5):1138-1142. Epub 2019 Sep 7. PMID: 31493208. DOI: 10.1007/s11096-019-00897-1..
        1       Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):36-43. PMID: 11833513. DOI: 10.1331/108658002763538053..
1     1 1       Bungay KM, Adler DA, Rogers WH, McCoy C, Kaszuba M, Supran S, Pei Y, Cynn DJ, Wilson IB. Description of a clinical pharmacist intervention administered to primary care patients with depression. Gen Hosp Psychiatry. 2004 May-Jun;26(3):210-8. PMID: 15121349. DOI: 10.1016/j.genhosppsych.2004.01.004..
  1 1           Butala N, Williams A, Kneebusch J, Mitchell M. Impact of a pharmacist-driven tardive dyskinesia screening service. Ment Health Clin. 2021 Jul 16;11(4):248-253. eCollection 2021 Jul. PMID: 34316421. DOI: 10.9740/mhc.2021.07.248..
  1             Byrd KK, Hardnett F, Hou JG, Clay PG, Suzuki S, Camp NM, Shankle MD, Weidle PJ, Taitel MS; Patient-Centered HIV Care Model Team. Improvements in Retention in Care and HIV Viral Suppression Among Persons with HIV and Comorbid Mental Health Conditions: Patient-Centered HIV Care Model. AIDS Behav. 2020 Dec;24(12):3522-3532. PMID: 32415615. DOI: 10.1007/s10461-020-02913-2..
  1       1 1 1 Caballero J, Souffrant G, Heffernan E. Development and outcomes of a psychiatric pharmacy clinic for indigent patients. Am J Health Syst Pharm. 2008 Feb 1;65(3):229-33. PMID: 18216008. DOI: 10.2146/ajhp070266..
  1 1           Campbell NL, Perkins AJ, Khan BA, Gao S, Farber MO, Khan S, Wang S, Boustani MA. Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit. J Am Geriatr Soc. 2019 Apr;67(4):695-702. Epub 2019 Jan 21. PMID: 30664239. DOI: 10.1111/jgs.15751..
  1 1           Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm. 2001 Jul 15;58(14):1309-16. PMID: 11471478. DOI: 10.1093/ajhp/58.14.1309..
1 1     1       Capoccia KL, Boudreau DM, Blough DK, Ellsworth AJ, Clark DR, Stevens NG, Katon WJ, Sullivan SD. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm. 2004 Feb 15;61(4):364-72. PMID: 15011764. DOI: 10.1093/ajhp/61.4.364..
1             1 Cardoni AA, Gunning J. Psychiatric pharmacy in a partial hospital program. Hosp Pharm. 1983 Oct;18(10):543-9, 555. PMID: 10263894FALSE.
  1         1 1 Carrión JA, Gonzalez-Colominas E, García-Retortillo M, Cañete N, Cirera I, Coll S, Giménez MD, Márquez C, Martin-Escudero V, Castellví P, Navinés R, Castaño JR, Galeras JA, Salas E, Bory F, Martín-Santos R, Solà R. A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C. J Hepatol. 2013 Nov;59(5):926-33. Epub 2013 Jun 26. PMID: 23811030. DOI: 10.1016/j.jhep.2013.06.019..
  1       1     Casey T, Johnson C, Love D. Adult attention deficit hyperactivity disorder clinic: An interprofessional collaboration. J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5S):S113-S117. Epub 2020 Jun 30. PMID: 32616446. DOI: 10.1016/j.japh.2020.03.020..
        1       Chavez B, Kosirog E. Impact on an integrated psychiatric pharmacy service in a primary care clinic. Ment Health Clin. 2019 Jul 1;9(4):269-274. eCollection 2019 Jul. PMID: 31293846. DOI: 10.9740/mhc.2019.07.269..
  1   1         Chen T, Kazerooni R, Vannort EM, Nguyen K, Nguyen S, Harris J, Bounthavong M. Comparison of an intensive pharmacist-managed telephone clinic with standard of care for tobacco cessation in a veteran population. Health Promot Pract. 2014 Jul;15(4):512-20. Epub 2013 Nov 14. PMID: 24231631. DOI: 10.1177/1524839913509816..
  1             Chen Z, Wang L, Chen K, Mi Q, Zu X, Xu Q, Na W, He W, Li X, Xu C, Wang F, Shen C, Shao L, Tang C, Shen X. The effects of a multi-disciplinary team on sleep quality assessment in mild-to-moderate Alzheimer's disease patients with sleep disorders. Scott Med J. 2021 Aug;66(3):134-141. Epub 2021 Jul 5. PMID: 34225517. DOI: 10.1177/00369330211027450..
  1             Cheng HM, Liu WC, Chua G, Liew CF, Li W, Choo W, Oon HH. Impact of a pharmacy-led smoking cessation clinic in a dermatology centre. Singapore Med J. 2019 Jan;60(1):31-33. Epub 2018 May 18. PMID: 29774362. DOI: 10.11622/smedj.2018063..
        1       Chung B, Dopheide JA, Gregerson P. Psychiatric pharmacist and primary care collaboration at a skid-row safety-net clinic. J Natl Med Assoc. 2011 Jul;103(7):567-74. PMID: 21999031. DOI: 10.1016/s0027-9684(15)30382-5..
        1   1 1 Cobb CD. Optimizing medication use with a pharmacist-provided comprehensive medication management service for patients with psychiatric disorders. Pharmacotherapy. 2014 Dec;34(12):1336-40. Epub 2014 Oct 20. PMID: 25329409. DOI: 10.1002/phar.1503..
  1       1     Condinho M, Ramalhinho I, Sinogas C. Smoking Cessation at the Community Pharmacy: Determinants of Success from a Real-Life Practice. Pharmacy (Basel). 2021 Aug 19;9(3):143. PMID: 34449711. DOI: 10.3390/pharmacy9030143..
  1             Costello MJ, Sproule B, Victor JC, Leatherdale ST, Zawertailo L, Selby P. Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers. Cancer Causes Control. 2011 Feb;22(2):167-80. Epub 2010 Dec 12. PMID: 21153694. DOI: 10.1007/s10552-010-9672-9..
  1     1       Crockett J, Taylor S, Grabham A, Stanford P. Patient outcomes following an intervention involving community pharmacists in the management of depression. Aust J Rural Health. 2006 Dec;14(6):263-9. PMID: 17121506. DOI: 10.1111/j.1440-1584.2006.00827.x..
  1             Davis TD, Deen T, Bryant-Bedell K, Tate V, Fortney J. Does minority racial-ethnic status moderate outcomes of collaborative care for depression?. Psychiatr Serv. 2011 Nov;62(11):1282-8. PMID: 22211206. DOI: 10.1176/ps.62.11.pss6211_1282..
1         1     DeCaporale-Ryan LN, Ahmed-Sarwar N, Upham R, Mahler K, Lashway K. Reducing hospital readmission through team-based primary care: A 7-week pilot study integrating behavioral health and pharmacy. Fam Syst Health. 2017 Jun;35(2):217-226. PMID: 28617022. DOI: 10.1037/fsh0000269..
  1             Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009 Feb;43(2):194-201. Epub 2009 Feb 3. PMID: 19193572. DOI: 10.1345/aph.1L556..
  1       1   1 Dent LA, Scott JG, Lewis E. Pharmacist-managed tobacco cessation program in Veterans Health Administration community-based outpatient clinic. J Am Pharm Assoc (2003). 2004 Nov-Dec;44(6):700-14; quiz 714-5. PMID: 15637853. DOI: 10.1331/1544345042467290..
  1             Dhital R, Norman I, Whittlesea C, Murrells T, McCambridge J. The effectiveness of brief alcohol interventions delivered by community pharmacists: randomized controlled trial. Addiction. 2015 Oct;110(10):1586-94. Epub 2015 Jul 14. PMID: 25988589. DOI: 10.1111/add.12994..
  1   1     1   DiPaula BA, Menachery E. Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients. J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):187-92. PMID: 25749264. DOI: 10.1331/JAPhA.2015.14177..
              1 Dobbs JH. Drug histories obtained by pharmacists from psychiatric inpatients. Hosp Community Psychiatry. 1981 Sep;32(9):639-40. PMID: 7275041. DOI: 10.1176/ps.32.9.639..
        1       Doescher MP, Whinston MA, Goo A, Cummings D, Huntington J, Saver BG. Pilot study of enhanced tobacco-cessation services coverage for low-income smokers. Nicotine Tob Res. 2002;4 Suppl 1:S19-24. PMID: 11945215. DOI: 10.1080/14622200210128045..
1 1 1           Dorevitch A, Aronzon R, Zilberman L. Medication maintenance of chronic schizophrenic out-patients by a psychiatric clinical pharmacist: 10-year follow-up study. J Clin Pharm Ther. 1993 Jun;18(3):183-6. PMID: 8102143. DOI: 10.1111/j.1365-2710.1993.tb00610.x..
  1     1     1 Dorevitch A, Perl E. The impact of clinical pharmacy intervention in a psychiatric hospital. J Clin Pharm Ther. 1996 Feb;21(1):45-8. PMID: 8737183. DOI: 10.1046/j.1365-2710.1996.89575895.x..
                Doyle D, Emmett M, Crist A, Robinson C, Grome M. Improving the Care of Dual Eligible Patients in Rural Federally Qualified Health Centers: The Impact of Care Coordinators and Clinical Pharmacists. J Prim Care Community Health. 2016 Apr;7(2):118-21. Epub 2015 Nov 18. PMID: 26582045. DOI: 10.1177/2150131915617297..
1 1             Dugas JE, Brown S. Community mental health centers: a milieu for expansion of pharmacist services. Hosp Pharm. 1978 Feb;13(2):78, 81-2, 84 passim. PMID: 10306348FALSE.
  1             El Hajj MS, Kheir N, Al Mulla AM, Shami R, Fanous N, Mahfoud ZR. Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial. BMC Public Health. 2017 Feb 20;17(1):215. PMID: 28219367. DOI: 10.1186/s12889-017-4103-4..
1           1 1 Ellenor GL, Frisk PA. Pharmacist impact on drug use in an institution for the mentally retarded. Am J Hosp Pharm. 1977 Jun;34(6):604-8. PMID: 879182FALSE.
  1             Eshiet UI, Okonta JM, Ukwe CV. Evaluating the impact of pharmaceutical care services on the clinical outcomes of epilepsy: a randomised controlled trial. Ir J Med Sci. 2021 Mar 27. Online ahead of print. PMID: 33774765. DOI: 10.1007/s11845-021-02599-y..
  1             Eshiet UI, Okonta JM, Ukwe CV. Impact of a pharmacist-led education and counseling interventions on quality of life in epilepsy: A randomized controlled trial. Epilepsy Res. 2021 Aug;174:106648. Epub 2021 Apr 27. PMID: 33945920. DOI: 10.1016/j.eplepsyres.2021.106648..
    1   1       Evans RL, Kirk RF, Walker PW, Rosenbluth SA, McDonald J. Medication maintenance of mentally ill patients by a pharmacist in a community setting. Am J Hosp Pharm. 1976 Jul;33(7):635-8. PMID: 941914FALSE.
  1             Fai SC, Yen GK, Malik N. Quit rates at 6 months in a pharmacist-led smoking cessation service in Malaysia. Can Pharm J (Ott). 2016 Sep;149(5):303-312. Epub 2016 Aug 9. PMID: 27708676. DOI: 10.1177/1715163516662894..
1 1     1       Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Bero LA. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002 Aug 15;59(16):1518-26. PMID: 12185826. DOI: 10.1093/ajhp/59.16.1518..
1 1     1       Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Lee JY, Bero LA. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy. 2003 Sep;23(9):1175-85. PMID: 14524649. DOI: 10.1592/phco.23.10.1175.32760..
  1             Fleming D, Raynsford J, Hosalli P. Reducing long acting antipsychotic injection dosage frequency: A pilot study in a community mental health team. J Ment Health. 2020 Jan 25:1-5. Online ahead of print. PMID: 31984826. DOI: 10.1080/09638237.2020.1714003..
  1 1           Forinash AB, Yancey A, Chamness D, Koerner J, Inteso C, Miller C, Gross G, Mathews K. Smoking Cessation Following Text Message Intervention in Pregnant Women. Ann Pharmacother. 2018 Nov;52(11):1109-1116. Epub 2018 Jun 1. PMID: 29857773. DOI: 10.1177/1060028018780448..
  1             Fortney JC, Pyne JM, Kimbrell TA, Hudson TJ, Robinson DE, Schneider R, Moore WM, Custer PJ, Grubbs KM, Schnurr PP. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. PMID: 25409287. DOI: 10.1001/jamapsychiatry.2014.1575..
  1             Fortney JC, Pyne JM, Mouden SB, Mittal D, Hudson TJ, Schroeder GW, Williams DK, Bynum CA, Mattox R, Rost KM. Practice-based versus telemedicine-based collaborative care for depression in rural federally qualified health centers: a pragmatic randomized comparative effectiveness trial. Am J Psychiatry. 2013 Apr;170(4):414-25. PMID: 23429924. DOI: 10.1176/appi.ajp.2012.12050696..
  1             Furbish SML, Kroehl ME, Loeb DF, Lam HM, Lewis CL, Nelson J, Chow Z, Trinkley KE. A Pharmacist-Physician Collaboration to Optimize Benzodiazepine Use for Anxiety and Sleep Symptom Control in Primary Care. J Pharm Pract. 2017 Aug;30(4):425-433. Epub 2016 Aug 1. PMID: 27480874. DOI: 10.1177/0897190016660435..
    1           Furniss L, Burns A, Craig SK, Scobie S, Cooke J, Faragher B. Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry. 2000 Jun;176:563-7. PMID: 10974963. DOI: 10.1192/bjp.176.6.563..
1 1             Gibu M, Clark J, Gold J. Mental health pharmacists as interim prescribers. Ment Health Clin. 2018 Mar 23;7(3):111-115. eCollection 2017 May. PMID: 29955508. DOI: 10.9740/mhc.2017.05.111..
  1             Gobarani RK, Zwar NA, Russell G, Abramson MJ, Bonevski B, Holland AE, Paul E, Cox NS, Wilson S, George J. Smoking cessation intervention in Australian general practice: a secondary analysis of a cluster randomised controlled trial. Br J Gen Pract. 2021 May 27;71(707):e458-e464. Print 2021 Jun. PMID: 33947668. DOI: 10.3399/BJGP.2020.0906..
  1             Gong J, Baker CL, Zou KH, Bruno M, Jumadilova Z, Lawrence D, Wilson B, Ewel C. A Pragmatic Randomized Trial Comparing Telephone-Based Enhanced Pharmacy Care and Usual Care to Support Smoking Cessation. J Manag Care Spec Pharm. 2016 Dec;22(12):1417-1425. PMID: 27882838. DOI: 10.18553/jmcp.2016.22.12.1417..
  1             Gonzalvo JD, Hamm JA, Shan M. A pharmacist-managed cardiovascular risk-reduction clinic for individuals experiencing serious mental illness. J Am Pharm Assoc (2003). 2019 Sep-Oct;59(5):698-703. Epub 2019 Jul 16. PMID: 31324536. DOI: 10.1016/j.japh.2019.06.012..
1   1   1   1   Gray DR, Namikas EA, Sax MJ, Brinkman J, Cheung A, Gordon M, Parker AG, Welch PH 3rd. Clinical pharmacists as allied health care providers to psychiatric patients. Contemp Pharm Pract. 1979 Summer;2(3):108-16. PMID: 10242843FALSE.
1     1         Gustafsson M, Sjölander M, Pfister B, Jonsson J, Schneede J, Lövheim H. Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial. Eur J Clin Pharmacol. 2017 Jul;73(7):827-835. Epub 2017 Apr 8. PMID: 28391409. DOI: 10.1007/s00228-017-2249-8..
1             1 Gustafsson M, Sjölander M, Pfister B, Schneede J, Lövheim H. Effects of Pharmacists' Interventions on Inappropriate Drug Use and Drug-Related Readmissions in People with Dementia-A Secondary Analysis of a Randomized Controlled Trial. Pharmacy (Basel). 2018 Jan 16;6(1):7. PMID: 29337859. DOI: 10.3390/pharmacy6010007..
  1             Hadi MA, Alldred DP, Briggs M, Marczewski K, Closs SJ. Effectiveness of a community based nurse-pharmacist managed pain clinic: A mixed-methods study. Int J Nurs Stud. 2016 Jan;53:219-27. Epub 2015 Sep 8. PMID: 26384958. DOI: 10.1016/j.ijnurstu.2015.09.003..
  1             Hansen RA, Dusetzina SB, Song L, Gaynes BN, Tu W, Murray MD. Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. J Am Pharm Assoc (2003). 2009 Nov-Dec;49(6):760-8. PMID: 19926556. DOI: 10.1331/JAPhA.2009.08184..
  1             Harms M, Haas M, Larew J, DeJongh B. Impact of a mental health clinical pharmacist on a primary care mental health integration team. Ment Health Clin. 2018 Mar 23;7(3):101-105. eCollection 2017 May. PMID: 29955506. DOI: 10.9740/mhc.2017.05.101..
1             1 Hefazi E, Boggie D, Huynh T, Lee KC. Influence of Psychotropic Medications on Readmission Rates of Patients Receiving a Pharmacist Discharge Medication Reconciliation. J Pharm Pract. 2020 Feb 18:897190020904466. Online ahead of print. PMID: 32067567. DOI: 10.1177/0897190020904466..
      1         Heins K. Fairview Pharmacy Services clozapine monitoring program: Description and evaluation of a clinical pharmacy service. Ment Health Clin. 2019 May 10;9(3):138-140. eCollection 2019 May. PMID: 31123662. DOI: 10.9740/mhc.2019.05.138..
  1           1 Henrichsmann M, Hempel G. Impact of medication therapy management in patients with Parkinson's disease. Int J Clin Pharm. 2016 Feb;38(1):54-60. Epub 2015 Nov 21. PMID: 26590989. DOI: 10.1007/s11096-015-0206-0..
  1             Herbert C, Winkler H. Impact of a clinical pharmacist-managed clinic in primary care mental health integration at a Veterans Affairs health system. Ment Health Clin. 2018 Apr 26;8(3):105-109. eCollection 2018 May. PMID: 29955554. DOI: 10.9740/mhc.2018.05.105..
                Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries. J Manag Care Pharm. 2009 Jan-Feb;15(1):32-41. PMID: 19125548. DOI: 10.18553/jmcp.2009.15.1.32..
    1         1 Hoffmann RP, Moore WE, O'Dea L. A potential role for the pharmacist. Medicine problems confronted by the schizophrenic outpatient. J Am Pharm Assoc. 1974 May;14(5):252-6 passim. PMID: 4831215. DOI: 10.1016/s0003-0465(16)32982-2..
  1     1     1 Hohmann C, Klotz JM, Radziwill R, Jacobs AH, Kissel T. Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life. Pharm World Sci. 2009 Oct;31(5):550-558. Epub 2009 Jul 25. PMID: 19633917. DOI: 10.1007/s11096-009-9315-y..
        1       Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Adherence to hospital discharge medication in patients with ischemic stroke: a prospective, interventional 2-phase study. Stroke. 2013 Feb;44(2):522-4. Epub 2012 Dec 6. PMID: 23223505. DOI: 10.1161/STROKEAHA.112.678847..
  1             Hohmann C, Radziwill R, Klotz JM, Jacobs AH. Health-related quality of life after ischemic stroke: the impact of pharmaceutical interventions on drug therapy (pharmaceutical care concept). Health Qual Life Outcomes. 2010 Jun 18;8:59. PMID: 20565872. DOI: 10.1186/1477-7525-8-59..
                Hunter CL, Ni Chroinin D, McEvoy L, Chuan A. Delirium Reduction by Analgesia Management in Hip Fracture surgery (DRAM-HF): Exploration of perceived facilitators and barriers. Australas J Ageing. 2021 Aug 16. Online ahead of print. PMID: 34397137. DOI: 10.1111/ajag.12991..
  1             Jaffray M, Matheson C, Bond CM, Lee AJ, McLernon DJ, Johnstone A, Skea L, Davidson B. Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial. Int J Pharm Pract. 2014 Feb;22(1):4-12. Epub 2013 Jul 3. PMID: 23822820. DOI: 10.1111/ijpp.12049..
                Johnson MR, Nash DR, Laird MR, Kiley RC, Martinez MA. Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol. J Pediatr Pharmacol Ther. 2014 Jul;19(3):165-73. PMID: 25309146. DOI: 10.5863/1551-6776-19.3.165..
  1       1     Jones TE, Crocker H, Ruffin RE. Smoking habits and cessation programme in an Australian teaching hospital. Aust N Z J Med. 1998 Aug;28(4):446-52. PMID: 9777112. DOI: 10.1111/j.1445-5994.1998.tb02079.x..
1     1         Kable A, Hullick C, Palazzi K, Oldmeadow C, Searles A, Ling R, Pond D, Fullerton A, Fraser S, Bruce R, Murdoch W, Attia J. Evaluation of a safe medication strategy intervention for people with dementia with an unplanned admission: Results from the Safe Medication Strategy Dementia Study. Australas J Ageing. 2021 Dec;40(4):356-365. Epub 2020 Nov 9. PMID: 33166034. DOI: 10.1111/ajag.12877..
  1             Kanwal F, Pyne JM, Tavakoli-Tabasi S, Nicholson S, Dieckgraefe B, Storay E, Bidwell Goetz M, Smith DL, Sansgiry S, Gifford A, Asch SM. Collaborative Care for Depression in Chronic Hepatitis C Clinics. Psychiatr Serv. 2016 Oct 1;67(10):1076-1082. Epub 2016 Jul 1. PMID: 27364808. DOI: 10.1176/appi.ps.201400474..
  1             Kanwal F, Pyne JM, Tavakoli-Tabasi S, Nicholson S, Dieckgraefe B, Storay E, Goetz MB, Kramer JR, Smith D, Sansgiry S, Tansel A, Gifford AL, Asch SM. A Randomized Trial of Off-Site Collaborative Care for Depression in Chronic Hepatitis C Virus. Health Serv Res. 2018 Aug;53(4):2547-2566. Epub 2017 Sep 11. PMID: 28891153. DOI: 10.1111/1475-6773.12758..
                Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):51-6. PMID: 11833517. DOI: 10.1331/108658002763538071..
    1         1 Kersten H, Hvidsten LT, Gløersen G, Wyller TB, Wang-Hansen MS. Clinical impact of potentially inappropriate medications during hospitalization of acutely ill older patients with multimorbidity. Scand J Prim Health Care. 2015;33(4):243-51. Epub 2015 Nov 9. PMID: 26553225. DOI: 10.3109/02813432.2015.1084766..
    1           Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2013 Mar;68(3):271-8. Epub 2012 Sep 14. PMID: 22982689. DOI: 10.1093/gerona/gls176..
  1     1       Khan N, Anderson JR, Du J, Tinker D, Bachyrycz AM, Namdar R. Smoking cessation and its predictors: results from a community-based pharmacy tobacco cessation program in New Mexico. Ann Pharmacother. 2012 Sep;46(9):1198-204. Epub 2012 Aug 21. PMID: 22911338. DOI: 10.1345/aph.1P146..
  1             Lertsinudom S, Kaewketthong P, Chankaew T, Chinwong D, Chinwong S. Smoking Cessation Services by Community Pharmacists: Real-World Practice in Thailand. Int J Environ Res Public Health. 2021 Nov 12;18(22):11890. PMID: 34831660. DOI: 10.3390/ijerph182211890..
1               Li H, Naqvi IA, Tom SE, Almeida B, Baratt Y, Ulane CM. Integrating neurology and pharmacy through telemedicine: A novel care model. J Neurol Sci. 2022 Jan 15;432:120085. Epub 2021 Dec 9. PMID: 34915405. DOI: 10.1016/j.jns.2021.120085..
  1             Li VW, Lam J, Heise P, Reid RD, Mullen KA. Implementation of a Pharmacist-Led Inpatient Tobacco Cessation Intervention in a Rehabilitation Hospital: A Before-and-After Pilot Study. Can J Hosp Pharm. 2018 May-Jun;71(3):180-186. Epub 2018 Jun 28. PMID: 29955191FALSE.
  1     1       Lindell VA, Stencel NL, Ives RC, Ward KM, Fluent T, Choe HM, Bostwick JR. A Pilot Evaluating Clinical Pharmacy Services in an Ambulatory Psychiatry Setting. Psychopharmacol Bull. 2018 Feb 5;48(2):18-28. PMID: 29713097FALSE.
  1             Litke J, Spoutz L, Ahlstrom D, Perdew C, Llamas W, Erickson K. Impact of the clinical pharmacy specialist in telehealth primary care. Am J Health Syst Pharm. 2018 Jul 1;75(13):982-986. PMID: 29941537. DOI: 10.2146/ajhp170633..
  1           1 Lizer MH, Parnapy Jawaid SA, Marsh W, Mogili L. The impact of a pharmacist assisted clinic upon medication adherence and quality of life in mental health patients. Pharm Pract (Granada). 2011 Jul;9(3):122-7. Epub 2011 Sep 14. PMID: 24367465FALSE.
              1 Lombardi N, Wei L, Ghaleb M, Pasut E, Leschiutta S, Rossi P, Troncon MG. Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy. BMC Health Serv Res. 2018 Apr 10;18(1):259. PMID: 29631587. DOI: 10.1186/s12913-018-2988-y..
1 1             Louzon P, Jennings H, Ali M, Kraisinger M. Impact of pharmacist management of pain, agitation, and delirium in the intensive care unit through participation in multidisciplinary bundle rounds. Am J Health Syst Pharm. 2017 Feb 15;74(4):253-262. PMID: 28179250. DOI: 10.2146/ajhp150942..
1               Lowrie R, Stock K, Lucey S, Knapp M, Williamson A, Montgomery M, Lombard C, Maguire D, Allan R, Blair R, Paudyal V, Mair FS. Pharmacist led homeless outreach engagement and non-medical independent prescribing (Rx) (PHOENIx) intervention for people experiencing homelessness: a non- randomised feasibility study. Int J Equity Health. 2021 Jan 7;20(1):19. PMID: 33413396. DOI: 10.1186/s12939-020-01337-7..
  1       1     Lui E, Wintemute K, Muraca M, Truong C, Ha R, Choe AKB, Michell L, Laine-Gossin J, Blankenstein H, Klein S, Mayer D, Feder V, Greiver M. Pharmacist-led sedative-hypnotic deprescribing in team-based primary care practice. Can Pharm J (Ott). 2021 Jun 11;154(4):278-284. eCollection 2021 Jul-Aug. PMID: 34345321. DOI: 10.1177/17151635211014918..
  1   1         Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001 Feb;96(2):325-31. PMID: 11182878. DOI: 10.1046/j.1360-0443.2001.96232516.x..
                Marawar R, Faraj M, Lucas K, Burns CV, Garwood CL. Implementation of an older adult epilepsy clinic utilizing pharmacist services. J Am Pharm Assoc (2003). 2021 Jul 10:S1544-3191(21)00304-6. Online ahead of print. PMID: 34330650. DOI: 10.1016/j.japh.2021.07.003..
  1             Mardle T, Merrett S, Wright J, Percival F, Lockhart I. Real world evaluation of three models of NHS smoking cessation service in England. BMC Res Notes. 2012 Jan 6;5:9. PMID: 22226240. DOI: 10.1186/1756-0500-5-9..
  1             Margulis A, Uhlyar S, Chin-Beckford N, DeRonde K, Salazar V, Abbo L, Vega A. Clinical pharmacist input on HIV management may improve antiretroviral prescribing for psychiatric patients. Am J Health Syst Pharm. 2020 Oct 10:zxaa310. Online ahead of print. PMID: 33037816. DOI: 10.1093/ajhp/zxaa310..
  1             Marín Armero A, Calleja Hernandez MA, Perez-Vicente S, Martinez-Martinez F. Pharmaceutical care in smoking cessation. Patient Prefer Adherence. 2015 Jan 29;9:209-15. eCollection 2015. PMID: 25678779. DOI: 10.2147/PPA.S67707..
  1     1       Marques LA, Galduróz JC, Fernandes MR, Oliveira CC, Beijo LA, Noto AR. Assessment of the effectiveness of pharmacotherapy follow-up in patients treated for depression. J Manag Care Pharm. 2013 Apr;19(3):218-27. PMID: 23537456. DOI: 10.18553/jmcp.2013.19.3.218..
  1           1 Maryan S, Harms M, McAllister E, DeJongh B. Comparison of clozapine monitoring and adverse event management in a psychiatrist-only and a clinical pharmacist-psychiatrist collaborative clinic. Ment Health Clin. 2019 Mar 1;9(2):70-75. eCollection 2019 Mar. PMID: 30842913. DOI: 10.9740/mhc.2019.03.070..
  1 1         1 McFadyen ML, Miller R, Juta M, Hodgson V. The relevance of a First-World therapeutic drug monitoring service to the treatment of epilepsy in Third-World conditions. S Afr Med J. 1990 Nov 17;78(10):587-90. PMID: 2247792FALSE.
1     1     1   McKee JR. Clinical pharmacy services in an intermediate care facility for the mentally retarded. Hosp Pharm. 1994 Mar;29(3):228-30, 233-4, 237. PMID: 10132698FALSE.
  1           1 McMillan SS, Kelly F, Hattingh HL, Fowler JL, Mihala G, Wheeler AJ. The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes. J Ment Health. 2018 Apr;27(2):164-173. Epub 2017 Jul 4. PMID: 28675321. DOI: 10.1080/09638237.2017.1340618..
  1             Meraya AM, Banji OJF, Khobrani MA, Alhossan A. Evaluation of psychotropic medications use among elderly with psychiatric disorders in Saudi Arabia. Saudi Pharm J. 2021 Jun;29(6):603-608. Epub 2021 Apr 24. PMID: 34194267. DOI: 10.1016/j.jsps.2021.04.021..
  1             Milkovich SA, Rychel RL, Pascuzzi KM, Purdum MB, Taylor GJ, Burant CJ, Leciejewski KA. Serious Mental Illness and Its Impact on Diabetes Care in a VA Nurse/ Pharmacist-Managed Population. Fed Pract. 2017 Oct;34(Suppl 8):S32-S37. PMID: 30766314FALSE.
  1           1 Mishra A, Krishna GS, Alla S, Kurian TD, Kurian J, Ramesh M, Kishor M. Impact of Pharmacist-Psychiatrist Collaborative Patient Education on Medication Adherence and Quality of Life (QOL) of Bipolar Affective Disorder (BPAD) Patients. Front Pharmacol. 2017 Oct 10;8:722. eCollection 2017. PMID: 29066976. DOI: 10.3389/fphar.2017.00722..
  1           1 Moga DC, Abner EL, Rigsby DN, Eckmann L, Huffmyer M, Murphy RR, Coy BB, Jicha GA. Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden. Alzheimers Res Ther. 2017 May 23;9(1):36. PMID: 28535785. DOI: 10.1186/s13195-017-0263-9..
  1             Mohd-Sidik S, Akhtari-Zavare M, Periasamy U, Rampal L, Fadhilah SI, Mahmud R. Effectiveness of chemotherapy counselling on self-esteem and psychological affects among cancer patients in Malaysia: Randomized controlled trial. Patient Educ Couns. 2018 May;101(5):862-871. Epub 2018 Jan 5. PMID: 29336859. DOI: 10.1016/j.pec.2018.01.004..
        1       Mooney EV, Hamper JG, Willis RT, Farinha TL, Ricchetti CA. Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy. J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S24-S29.e2. PMID: 30006184. DOI: 10.1016/j.japh.2018.04.035..
            1 1 Moore JM, Shartle D, Faudskar L, Matlin OS, Brennan TA. Impact of a patient-centered pharmacy program and intervention in a high-risk group. J Manag Care Pharm. 2013 Apr;19(3):228-36. PMID: 23537457. DOI: 10.18553/jmcp.2013.19.3.228..
    1         1 Najjar MF, Sulaiman SAS, Al Jeraisy M, Balubaid H. The impact of a combined intervention program: an educational and clinical pharmacist's intervention to improve prescribing pattern in hospitalized geriatric patients at King Abdulaziz Medical City in Riyadh, Saudi Arabia. Ther Clin Risk Manag. 2018 Mar 16;14:557-564. eCollection 2018. PMID: 29588595. DOI: 10.2147/TCRM.S157469..
  1             Nurkowski J, Elshorbagy H, Halpape K, Jensen K, Lamb DA, Landry E, Remillard A, Jorgenson D. Impact of Pharmacist-Led Cognitive Behavioural Therapy for Chronic Insomnia. Innov Pharm. 2020 Jul 31;11(3):10.24926/iip.v11i3.3378. eCollection 2020. PMID: 34007630. DOI: 10.24926/iip.v11i3.3378..
  1             Onda M, Horiguchi M, Domichi M, Sakane N. A Pragmatic Pilot Cluster-Randomized Study of Tobacco Screening and Smoking Cessation Program for Community Pharmacies in Japan: FINE Program. J Smok Cessat. 2021 Dec 3;2021:9983515. eCollection 2021. PMID: 34956405. DOI: 10.1155/2021/9983515..
  1             Onda M, Kuwanoe T, Hashimoto A, Horiguchi M, Domichi M, Sakane N. Pharmacist-Delivered Smoking Cessation Program in Community Pharmacy (The FINE Program) in Japan-The Development of a Training Course and a Feasibility Study. J Pharm Pract. 2019 Dec 13:897190019889745. Online ahead of print. PMID: 31835966. DOI: 10.1177/0897190019889745..
  1     1       Papastergiou J, Quilty LC, Li W, Thiruchselvam T, Jain E, Gove P, Mandlsohn L, van den Bemt B, Pojskic N. Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial. Clin Transl Sci. 2021 Feb 28. Online ahead of print. PMID: 33641259. DOI: 10.1111/cts.12986..
1           1   Paquin AM, Salow M, Rudolph JL. Pharmacist calls to older adults with cognitive difficulties after discharge in a Tertiary Veterans Administration Medical Center: a quality improvement program. J Am Geriatr Soc. 2015 Mar;63(3):571-7. Epub 2015 Mar 2. PMID: 25732548. DOI: 10.1111/jgs.13315..
    1           Pardo D, Miller L, Chiulli D. Implementation of a pharmacy consult to reduce co-prescribing of opioids and benzodiazepines in a Veteran population. Subst Abus. 2017 Apr-Jun;38(2):157-160. Epub 2017 Feb 6. PMID: 28166464. DOI: 10.1080/08897077.2017.1290011..
  1       1     Parikh M, Ebong EE, Harris E, Barnes B. Evaluation of clinical pharmacy services within the primary care-mental health integration model at the Tuscaloosa Veterans Affairs Medical Center. Ment Health Clin. 2016 Aug 31;6(5):260-265. eCollection 2016 Sep. PMID: 29955480. DOI: 10.9740/mhc.2016.09.260..
  1     1       Perepelkin J, Antunes K, Boechler L, Remillard AJ, Mildenberger L. Providing mindfulness meditation for patients with depression and anxiety in a community pharmacy: A pilot study. J Am Pharm Assoc (2003). 2019 Mar-Apr;59(2):258-264. Epub 2018 Dec 11. PMID: 30552050. DOI: 10.1016/j.japh.2018.10.017..
  1 1         1 Pham HT, Tran MH, Nguyen NQ, Tan Vo V, Tran MH. Role of clinical pharmacists in epilepsy management at a general hospital in Vietnam: a before-and-after study. J Pharm Policy Pract. 2021 Dec 20;14(1):109. PMID: 34930487. DOI: 10.1186/s40545-021-00394-9..
  1             Philbrick AM, Newkirk EN, Farris KB, McDanel DL, Horner KE. Effect of a pharmacist managed smoking cessation clinic on quit rates. Pharm Pract (Granada). 2009 Jul;7(3):150-6. Epub 2009 Mar 15. PMID: 25143792. DOI: 10.4321/s1886-36552009000300004..
  1             Phimarn W, Kaewphila P, Suttajit S, Saramunee K. Depression screening and advisory service provided by community pharmacist for depressive students in university. Springerplus. 2015 Sep 2;4:470. eCollection 2015. PMID: 26357601. DOI: 10.1186/s40064-015-1259-1..
  1     1       Poon LH, Lee AJ, Chiao TB, Kang GA, Heath S, Glass GA. Pharmacist's role in a Parkinson's disease and movement disorders clinic. Am J Health Syst Pharm. 2012 Mar 15;69(6):518-20. PMID: 22382484. DOI: 10.2146/ajhp110127..
  1     1       Pyne JM, Fortney JC, Curran GM, Tripathi S, Atkinson JH, Kilbourne AM, Hagedorn HJ, Rimland D, Rodriguez-Barradas MC, Monson T, Bottonari KA, Asch SM, Gifford AL. Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med. 2011 Jan 10;171(1):23-31. PMID: 21220657. DOI: 10.1001/archinternmed.2010.395..
  1         1   Pyne JM, Fortney JC, Tripathi SP, Maciejewski ML, Edlund MJ, Williams DK. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. Arch Gen Psychiatry. 2010 Aug;67(8):812-21. PMID: 20679589. DOI: 10.1001/archgenpsychiatry.2010.82..
1               Raynsford J, Dada C, Stansfield D, Cullen T. Impact of a specialist mental health pharmacy team on medicines optimisation in primary care for patients on a severe mental illness register: a pilot study. Eur J Hosp Pharm. 2020 Jan;27(1):31-35. Epub 2018 Jul 2. PMID: 32064086. DOI: 10.1136/ejhpharm-2018-001514..
  1     1       Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA. Improving patient feedback about and outcomes with antidepressant treatment: a study in eight community pharmacies. J Am Pharm Assoc (2003). 2006 Jan-Feb;46(1):25-32. PMID: 16529338. DOI: 10.1331/154434506775268715..
  1     1       Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA. Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. J Am Pharm Assoc (2003). 2005 May-Jun;45(3):344-53. PMID: 15991756. DOI: 10.1331/1544345054003732..
  1 1           Rojas-Fernandez CH, Eng M, Allie ND. Pharmacologic management by clinical pharmacists of behavioral and psychological symptoms of dementia in nursing home residents: results from a pilot study. Pharmacotherapy. 2003 Feb;23(2):217-21. PMID: 12587811. DOI: 10.1592/phco.23.2.217.32084..
1       1   1   Rosen CE, Copp WM, Holmes S. Effectiveness of a specially trained pharmacist in a rural community mental health center. Public Health Rep. 1978 Sep-Oct;93(5):464-7. PMID: 212774FALSE.
1       1       Rosen CE, Holmes S. Pharmacist's impact on chronic psychiatric outpatients in community mental health. Am J Hosp Pharm. 1978 Jun;35(6):704-8. PMID: 665683FALSE.
                Rubio-Valera M, March Pujol M, Fernández A, Peñarrubia-María MT, Travé P, López Del Hoyo Y, Serrano-Blanco A. Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: a randomized controlled superiority trial. Eur Neuropsychopharmacol. 2013 Sep;23(9):1057-66. Epub 2012 Dec 6. PMID: 23219937. DOI: 10.1016/j.euroneuro.2012.11.006..
  1             Sakakibara M, Igarashi A, Takase Y, Kamei H, Nabeshima T. Effects of Prescription Drug Reduction on Quality of Life in Community-Dwelling Patients with Dementia. J Pharm Pharm Sci. 2015;18(5):705-12. PMID: 26670367. DOI: 10.18433/j37p5x..
  1   1     1 1 Saklad SR, Ereshefsky L, Jann MW, Crismon ML. Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility. Drug Intell Clin Pharm. 1984 Jul-Aug;18(7-8):632-4. PMID: 6745092. DOI: 10.1177/106002808401800718..
1               Salazar-Ospina A, Amariles P, Hincapié-García JA, González-Avendaño S, Benjumea DM, Faus MJ, Rodriguez LF. Effectiveness of the Dader Method for Pharmaceutical Care on Patients with Bipolar I Disorder: Results from the EMDADER-TAB Study. J Manag Care Spec Pharm. 2017 Jan;23(1):74-84. PMID: 28025928. DOI: 10.18553/jmcp.2017.23.1.74..
1               Salazar-Ospina A, Amariles P, Hincapié-García JA, González-Avendaño S. Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study. Heliyon. 2020 Feb 11;6(2):e03333. eCollection 2020 Feb. PMID: 32072044. DOI: 10.1016/j.heliyon.2020.e03333..
  1             Sathienluckana T, Unaharassamee W, Suthisisang C, Suanchang O, Suansanae T. Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist-physician collaboration in the outpatient department. Integr Pharm Res Pract. 2018 Oct 26;7:161-171. eCollection 2018. PMID: 30464898. DOI: 10.2147/IPRP.S176653..
  1             Schneiderhan ME, Shuster SM, Davey CS. Twelve-month prospective randomized study of pharmacists utilizing point-of-care testing for metabolic syndrome and related conditions in subjects prescribed antipsychotics. Prim Care Companion CNS Disord. 2014 Oct 30;16(5):10.4088/PCC.14m01669. eCollection 2014. PMID: 25667811. DOI: 10.4088/PCC.14m01669..
  1             Schröder S, Martus P, Odin P, Schaefer M. Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's disease. Int J Clin Pharm. 2012 Oct;34(5):746-56. Epub 2012 Jul 19. PMID: 22810890. DOI: 10.1007/s11096-012-9672-9..
  1             Shen X, Bachyrycz A, Anderson JR, Tinker D, Raisch DW. Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New Mexico. J Manag Care Spec Pharm. 2014 Jun;20(6):579-87. PMID: 24856596. DOI: 10.18553/jmcp.2014.20.6.579..
  1         1   Shilpa HSS, Kumar NN, Maheswari E, Virupaksha HS, Subeesh V, Saraswathy GR, Kunnavil R. Deprescribing of benzodiazepines and Z-drugs amongst the psychiatric patients of a tertiary care Hospital. Asian J Psychiatr. 2019 Aug;44:189-194. Epub 2019 Jul 29. PMID: 31408799. DOI: 10.1016/j.ajp.2019.07.041..
  1   1 1       Silvia R, Plum M, Dufresne R. Efficiencies and outcomes of depression treatment by a psychiatric pharmacist in a primary care clinic compared with treatment within a behavioral health clinic. J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5S):S98-S106. Epub 2020 Jul 12. PMID: 32665098. DOI: 10.1016/j.japh.2020.05.015..
            1 1 Sjölander M, Lindholm L, Pfister B, Jonsson J, Schneede J, Lövheim H, Gustafsson M. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation. Res Social Adm Pharm. 2019 Mar;15(3):287-291. Epub 2018 May 16. PMID: 29778344. DOI: 10.1016/j.sapharm.2018.05.006..
  1       1     Smith A, Hansen J, Colvard M. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention. J Subst Abuse Treat. 2021 Apr 28;130:108440. Online ahead of print. PMID: 34118708. DOI: 10.1016/j.jsat.2021.108440..
    1   1 1     Smith MD, McGhan WF, Lauger G. Pharmacist counseling and outcomes of smoking cessation. Am Pharm. 1995 Aug;NS35(8):20-9; 32. PMID: 7677052. DOI: 10.1016/s0160-3450(15)30095-7..
1   1           Steineck KJ, Skoglund AK, Carlson MK, Gupta S. Evaluation of a pharmacist-managed methadone taper*. Pediatr Crit Care Med. 2014 Mar;15(3):206-10. PMID: 24448326. DOI: 10.1097/PCC.0000000000000048..
              1 Stimmel GL, McGhan WF, Wincor MZ, Deandrea DM. Comparison of pharmacist and physician prescribing for psychiatric inpatients. Am J Hosp Pharm. 1982 Sep;39(9):1483-6. PMID: 6127948FALSE.
  1             Stoner SC, Worrel JA, Jones MT, Farrar CA, Ramlatchman LV. Pharmacist-designed and -implemented pharmaceutical care plan for antipsychotic-induced movement disorders. Pharmacotherapy. 2000 May;20(5):583-8. PMID: 10809346. DOI: 10.1592/phco.20.6.583.35159..
  1           1 Stuhec M, Bratović N, Mrhar A. Impact of clinical pharmacist's interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: A prospective non-randomized study. Sci Rep. 2019 Nov 14;9(1):16856. PMID: 31728029. DOI: 10.1038/s41598-019-53057-w..
  1             Stuhec M, Tement V. Positive evidence for clinical pharmacist interventions during interdisciplinary rounding at a psychiatric hospital. Sci Rep. 2021 Jul 1;11(1):13641. PMID: 34211019. DOI: 10.1038/s41598-021-92909-2..
                Stuhec M. Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement. Int J Clin Pharm. 2021 Jul 6. Online ahead of print. PMID: 34228266. DOI: 10.1007/s11096-021-01306-2..
  1     1       Stuijt C, Karapinar-Çarkit F, van den Bemt B, van Laar T. Effect of Pharmacist-Led Interventions on (Non)Motor Symptoms, Medication-Related Problems, and Quality of Life in Parkinson Disease Patients: A Pilot Study. Clin Neuropharmacol. 2018 Jan/Feb;41(1):14-19. PMID: 29300205. DOI: 10.1097/WNF.0000000000000260..
  1             Suehs BT, Mican LM, Campbell AH. Retrospective evaluation of an inpatient psychiatric pharmacist consultation service. J Am Pharm Assoc (2003). 2011 Sep-Oct;51(5):599-604. PMID: 21896457. DOI: 10.1331/JAPhA.2011.10107..
1 1   1         Summers B, Summers RS, Rom S. The effect of a specialist clinic with pharmacist involvement on the management of epilepsy in paediatric patients. J Clin Hosp Pharm. 1986 Jun;11(3):207-14. PMID: 3745470. DOI: 10.1111/j.1365-2710.1986.tb00846.x..
  1   1 1       Suzuki J, Matthews ML, Brick D, Nguyen MT, Wasan AD, Jamison RN, Ellner AL, Tishler LW, Weiss RD. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically. J Opioid Manag. 2014 May-Jun;10(3):159-68. PMID: 24944066. DOI: 10.5055/jom.2014.0204..
        1       Swain LD. A pharmacist's contribution to an ambulatory neurology clinic. Consult Pharm. 2012 Jan;27(1):49-57. PMID: 22231998. DOI: 10.4140/TCP.n.2012.49..
                Taveira TH, Dooley AG, Cohen LB, Khatana SA, Wu WC. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Ann Pharmacother. 2011 Nov;45(11):1346-55. Epub 2011 Oct 25. PMID: 22028418. DOI: 10.1345/aph.1Q212..
  1       1     Taveira TH, Pirraglia PA, Cohen LB, Wu WC. Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions. Prev Cardiol. 2008 Fall;11(4):195-200. PMID: 19476571. DOI: 10.1111/j.1751-7141.2008.00008.x..
    1         1 Thayer N, White S, Islam J, Jones W, Kenzie S, Kullu R. Reducing risks associated with medicines and lifestyle in a residential care population with intellectual disabilities: evaluation of a pharmacy review initiative in England. BMJ Open. 2021 Aug 17;11(8):e046630. PMID: 34404698. DOI: 10.1136/bmjopen-2020-046630..
  1     1       Thomas D, Abramson MJ, Bonevski B, Taylor S, Poole SG, Paul E, Weeks GR, Dooley MJ, George J. Integrating smoking cessation into routine care in hospitals--a randomized controlled trial. Addiction. 2016 Apr;111(4):714-23. Epub 2016 Jan 13. PMID: 26597421. DOI: 10.1111/add.13239..
  1 1           Tse SS, Sands BE, Keefer L, Cohen BL, Maser E, Ungaro RC, Marion JF, Colombel JF, Itzkowitz SH, Gelman J, Dubinsky MC. Improved Smoking Cessation Rates in a Pharmacist-Led Program Embedded in an Inflammatory Bowel Disease Specialty Medical Home. J Pharm Pract. 2021 Apr 8:8971900211000682. Online ahead of print. PMID: 33827316. DOI: 10.1177/08971900211000682..
  1             Ummavathy P, Sherina MS, Rampal L, Siti Irma Fadhilah I. Outcome of chemotherapy counseling by pharmacists on psychological effects and self esteem among oncology patients in a Government Hospital in Malaysia. Med J Malaysia. 2015 Jun;70(3):131-41. PMID: 26248774FALSE.
        1       Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull. 2011 Jul;37(4):727-36. Epub 2009 Nov 21. PMID: 19933540. DOI: 10.1093/schbul/sbp121..
  1 1           van Velthuijsen EL, Zwakhalen SMG, Pijpers E, van de Ven LI, Ambergen T, Mulder WJ, Verhey FRJ, Kempen GIJM. Effects of a Medication Review on Delirium in Older Hospitalised Patients: A Comparative Retrospective Cohort Study. Drugs Aging. 2018 Feb;35(2):153-161. PMID: 29396715. DOI: 10.1007/s40266-018-0523-9..
  1           1 Wang I, Dopheide JA, Gregerson P. Role of a psychiatric pharmacist in a Los Angeles "Skid-Row" safety-net clinic. J Urban Health. 2011 Aug;88(4):718-23. PMID: 21512832. DOI: 10.1007/s11524-011-9573-6..
  1     1       Watanabe F, Shinohara K, Dobashi A, Amagai K, Hara K, Kurata K, Iizima H, Shimakawa K, Shimada M, Abe S, Takei K, Kamei M. Assessment of Assistance in Smoking Cessation Therapy by Pharmacies in Collaboration with Medical Institutions- Implementation of a Collaborative Drug Therapy Management Protocol Based on a Written Agreement between Physicians and Pharmacists. Yakugaku Zasshi. 2016;136(9):1243-54. PMID: 27592827. DOI: 10.1248/yakushi.16-00013..
        1       Watanabe N, Yamamura K, Suzuki Y, Umegaki H, Shigeno K, Matsushita R, Sai Y, Miyamoto K, Yamada K. Pharmacist-based Donepezil Outpatient Consultation Service to improve medication persistence. Patient Prefer Adherence. 2012;6:605-11. Epub 2012 Aug 28. PMID: 22969291. DOI: 10.2147/PPA.S34984..
  1             Watkins VA, Michaels NM, Jackson DL, Rhodes LA, Marciniak MW. The effect of community pharmacist-led health coaching on clinical outcomes. J Am Pharm Assoc (2003). 2020 May-Jun;60(3S):S65-S69. Epub 2020 May 18. PMID: 32439280. DOI: 10.1016/j.japh.2020.03.021..
    1         1 Westbury JL, Gee P, Ling T, Brown DT, Franks KH, Bindoff I, Bindoff A, Peterson GM. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust. 2018 May 21;208(9):398-403. Epub 2018 May 14. PMID: 29747564. DOI: 10.5694/mja17.00857..
        1       White D, Wright M, Baber B, Barrera A. A pilot study evaluating the effectiveness of a medicines education group in a mental health inpatient setting: A UK perspective. Ment Health Clin. 2018 Mar 23;7(3):116-123. eCollection 2017 May. PMID: 29955509. DOI: 10.9740/mhc.2017.05.116..
        1     1 Wolf-Klein GP, Levy AP, Silverstone FA, Smith H, Papain P, Foley CJ. Psychiatric profile of the noncompliant geriatric patient in the community. Int Psychogeriatr. 1989 Fall;1(2):177-84. PMID: 2491144. DOI: 10.1017/s1041610289000189..
1           1   Wright WA, Gorman JM, Odorzynski M, Peterson MJ, Clayton C. Integrated Pharmacies at Community Mental Health Centers: Medication Adherence and Outcomes. J Manag Care Spec Pharm. 2016 Nov;22(11):1330-1336. Epub 2016 Aug 11. PMID: 27783555. DOI: 10.18553/jmcp.2016.16004..
  1             Yasin H, Bulatova N, Wazaify M. Pharmaceutical Care in the Treatment of Substance Use Disorders in Jordan: A Randomized Controlled Trial. Subst Use Misuse. 2021;56(12):1846-1859. Epub 2021 Aug 4. PMID: 34348564. DOI: 10.1080/10826084.2021.1958852..
  1     1       Zillich AJ, Ryan M, Adams A, Yeager B, Farris K. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy. 2002 Jun;22(6):759-65. PMID: 12066966. DOI: 10.1592/phco.22.9.759.34073..